iRxReminder Announces Enrollment of Initial Patients in Groundbreaking Tardive Dyskinesia Detection Study
iRxReminder, LLC, a pioneer in medical adherence technology, is thrilled to announce the enrollment of its first patients in the innovative NIMH-funded study, the TDtect™ Diagnostic...
Behavioral Health Providers Eye TMS Expansion, But There Are Trade-Offs
Dr. Owen Muir chats with Behavioral Health Business about how outpatient mental health providers look for new options to improve patient outcomes and add a new service line to their business.
Tune Into Psychiatry's Next Frontier: Introducing the Psychiatry Tomorrow Podcast
In Psychiatry Tomorrow, we'll delve into the challenges and opportunities that lie ahead.
‘This Is a Life and Death Matter’: DEA Faces Tsunami of Criticism on Proposed Telehealth-Controlled Substances Rules
The two proposed rules from the Drug Enforcement Administration (DEA) that effectively undue controlled substances prescribing via telehealth...
New Psychiatric Clinic
At Fermata, patients can receive accelerated deep transcranial magnetic stimulation (TMS)...
‘The worst it’s ever been’: mysterious US Adderall shortage puts ADHD patients at risk
Modern physicians recognize stimulants as “the No 1 evidence-based treatment for ADHD”, says Dr Owen Muir, a Brooklyn-based psychiatrist who specializes in treating the disorder.
Business of Healthcare and Value Based Care - 2023 Health IT Predictions
Dr. Carlene MacMillan gives her healthcare predictions for 2023.
As Ketamine Clinics Expand, Concerns Grow About Staffing, Protocols and Take-it-at-Home Models
Carlene MacMillan, VP of clinical innovation of Osmind, a company that has worked with more than 300 clinics nationwide providing electronic health records, said she knows of one clinic that infuses patients five days in a row.
Getting Therapy When Cost and Access Are a Barrier
Mental health platforms like BetterHelp and Brightside make it possible to communicate with a therapist on a video or phone call, or through text. For kids and teens, MacMillan recommends Little Otter and Brightline
OCD and Deep TMS: Practical Applications
In this Q&A, Drs. Ryan Vidrine and Owen Muir discuss real-world experience with deep transcranial magnetic stimulation for patients with refractory obsessive compulsive disorder...
Press Coverage
Newsletter
Sign Up for the Fermata Mailing List!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
